“The second quarter was another strong quarter for Hyperfine as we continue to execute across our commercial, operational, and financial priorities,” Sainz said. In hospitals, Hyperfine said Model 2 deployments have moved beyond critical-care use into emergency departments, hospital-based clinics, neurological workflows and mobile deployment models. In France, Hyperfine said Model 2’s inclusion in the UniHA procurement listing provides a purchasing pathway for public hospitals. About Hyperfine (NASDAQ:HYPR)Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.